For a long time, human eEF1A2 has been known to behave as a pro-oncogenic protein, its aberrant expression increasing cancer cell fitness through the inhibition of apoptosis,12 control of misfolded proteins degradation,11 heat-shock response,27 reorganisation of actin cytoskeleton10 and regulation of oxidative stress.8 Several interaction partners have been described for eEF1A2 that are important to convey its pro-oncogenic properties, including PRDX1,8 SPHK16,7 and others. This evidence concerns the gene PRDX1 and cancer.